Overview

Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean Delivery

Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
0
Participant gender:
Female
Summary
In this study the investigators will compare two doses of norepinephrine bolus (6 mcg and 10 mcg) in management of maternal hypotensive episode after subarachnoid block during Cesarean delivery.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Cairo University
Treatments:
Bupivacaine
Norepinephrine
Criteria
Inclusion Criteria:

- Pregnant women

- Scheduled for cesarean delivery

Exclusion Criteria:

- Patients with severe cardiac dysfunction

- Patients with low blood pressure

- Patients with ante-partum bleeding